Investors seeking to increase their exposure to growth should consider companies such as Vincent Medical Holdings and Union Medical Healthcare. Analysts are generally optimistic about the future of these stocks, based on how much they’re expected to earn and return. I would suggest taking a look at my list of companies that compare favourably in all criteria, and consider whether they would add value to your current portfolio.
Vincent Medical Holdings Limited (SEHK:1612)
Vincent Medical Holdings Limited, an investment holding company, researches, develops, manufactures, markets, and sells medical devices. Started in 1997, and run by CEO Ki Cheung To, the company now has 1,016 employees and with the company’s market cap sitting at HKD HK$420.85M, it falls under the small-cap stocks category.
1612’s projected future profit growth is a robust 20.06%, with an underlying 20.56% growth from its revenues expected over the upcoming years. It appears that 1612’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. We see this bottom-line expansion directly benefiting shareholders, with expected positive return on equity of 10.30%. 1612’s impressive outlook on all aspects makes it a worthy company to spend more time to understand. Want to know more about 1612? I recommend researching its fundamentals here.
Union Medical Healthcare Limited (SEHK:2138)
Union Medical Healthcare Limited provides aesthetic medical services in Hong Kong. Founded in 2005, and currently run by Chi Tang, the company now has 852 employees and with the company’s market capitalisation at HKD HK$3.13B, we can put it in the mid-cap category.
2138 is expected to deliver an extremely high earnings growth over the next couple of years of 17.34%, driven by a positive double-digit revenue growth of 46.77% and cost-cutting initiatives. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 32.68%. 2138’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Could this stock be your next pick? Have a browse through its key fundamentals here.
Fu Shou Yuan International Group Limited (SEHK:1448)
Fu Shou Yuan International Group Limited, an investment holding company, primarily provides burial and funeral services in the People’s Republic of China. Established in 1994, and now led by CEO Jisheng Wang, the company currently employs 1,815 people and with the market cap of HKD HK$14.00B, it falls under the large-cap category.